05.10.2018 • Topics

Industry 4.0 Will Be a Game Changer for the Chemical Business

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Leading Transformation

The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Aenova Holding GmbH

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

most read

Topics • Chemistry

US Tariffs Fatal for European Pharma

Trump's tariff policy is a considerable burden and a break with previous practice.

Topics • Innovation

Lead or Lag: Europe’s AI Materials Race

How AI and Robotics are reshaping the race for materials discovery.

Topics • Pharma

Pharma 4.0—the Key Enabler for Successful Digital Transformation in Pharma

Part 3: Seven Theses for successful Digitalization in Pharma

20 Years of CHEManager International

Incredible but true: CHEManager International is celebrating its 20th anniversary!

Topics • Chemistry

Q1 2025 Chemical Industry: Diverging Trends

The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.